Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 31 Neoplasms 13 Stomach Neoplasms 11 Lung Neoplasms 11 Endometrial Neoplasms 11 Lymphatic Metastasis 7 Head and Neck Neoplasms 7 Carcinoma, Hepatocellular 7 Melanoma 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2

Interventions

pexidartinib 6 nilotinib 1 cabiralizumab 1 Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Giant Cell Tumor of Tendon Sheath × Indocyanine Green × Clear all

NCT07315841 2026-01-05

ICG-TGCT

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phase 4 Recruiting

Giant Cell Tumor of Tendon Sheath

Data powered by HemOnc (CC BY 4.0) Colophon ⚡